What You Should Know:
- Researchers at Cedars-Sinai have developed a new method using artificial intelligence (AI) to assess cardiovascular disease risk during a routine chest computed tomography (CT) scan without contrast dye.
- The recent study published in Nature Communications, could significantly reduce the cost and invasiveness of identifying patients at risk for heart disease.
Leveraging Existing Data for Better Risk Assessment
Traditionally, CT scans with contrast
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Generative AI in Healthcare Survey Reveals Rising Adoption Amidst Challenges
What You Should Know:
- John Snow Labs, the AI for healthcare company announced the findings of the inaugural Generative AI in Healthcare Survey. Conducted by Gradient Flow, the research explores the trends, tools, and behaviors around generative artificial intelligence (GenAI) use among healthcare and life sciences practitioners.
- Findings reveal a significant increase in GenAI budgets across the board, with one-fifth of all technical leaders witnessing a more than 300%
Read More
Philips Receives FDA 510(k) Clearance on Image-Guided Surgical Therapy
What You Should Know:
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its Philips Zenition 30 mobile C-arm has received FDA 510(k) clearance, making image-guided surgical procedures available to more US patients at lower cost.
- By giving surgeons greater flexibility, control, and
Read More
Blue Shield of California Expands Wellvolution Platform to Address Musculoskeletal Needs
What You Should Know:
- Blue Shield of California is expanding its popular digital health platform, Wellvolution, to offer comprehensive support for members experiencing musculoskeletal (MSK) issues.
- The expansion adds three new programs – SworkIt, Kaia, and Sword Health – to the existing suite of lifestyle medicine programs available on Wellvolution.
Wellvolution: A One-Stop Shop for Health Management
Developed in collaboration with Solera Health, Wellvolution empowers
Read More
Brigham and Women’s Hospital Uncovers $4.8M in Potential Savings, Announces New AI Study + Integration
What You Should Know:
- FeelBetter, the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced a collaboration on a prospective research study with investigators at Brigham and Women’s Hospital in Boston.
- The research will assess the impact of FeelBetter’s AI-based
Read More
Clarapath and Mayo Clinic Partner to Modernize Pathology Labs with Robotics, AI & Automation
What You Should Know:
- Clarapath, a medical robotics company on a mission to transform tissue processing in pathology labs, has announced a strategic collaboration with Mayo Clinic, a world-renowned leader in medical care and research.
- The strategic partnership marks a significant step towards a new era of automation and efficiency within pathology labs.
The Challenge: Manual Processes and Rising Demands
For decades, pathology labs have relied on manual,
Read More
DrFirst and PatchRx Partner to Combat Medication Non-Adherence
What You Should Know:
- Healthcare technology leader DrFirst has joined forces with medication adherence company PatchRx to tackle a major healthcare challenge: medication non-adherence.
- The strategic collaboration aims to improve patient health outcomes and reduce healthcare costs associated with patients not taking their medications as prescribed.
The Problem of Medication Non-Adherence
In the United States alone, medication non-adherence is estimated to contribute to
Read More
Deciphex & Novartis Partner on AI-Powered Pathology for Drug Discovery
What You Should Know:
- Deciphex, a leading digital pathology company based in Dublin, Ireland, has announced a collaborative effort with Novartis, a prominent multinational pharmaceutical corporation.
- The strategic partnership focuses on developing innovative artificial intelligence (AI) solutions aimed at revolutionizing preclinical pathology assessments within the drug discovery and development process.
Optimizing Preclinical Pathology with AI
The collaboration
Read More
Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device. With affordable, AI-powered medical imaging in a pocket-sized device, caregivers can get to answers immediately to accelerate diagnosis and create new care pathways for heart failure patients at the point of care. As
Read More
Ultrahuman Opens U.S. Manufacturing Facility for Wearable Rings
What You Should Know:
- With smart ring market leadership within its sights, Ultrahuman has today announced plans to open a manufacturing facility poised to accelerate its production capacity.
- The UltraFactory will be located in Indiana. It opens within the next six months and will be the launchpad for Ultrahuman’s next phase of growth.
Ultrahuman Sets Industry Benchmark with Launch of
Read More
